RAYDIAX
PrivateLast Round
Grant
Mar 1, 2026
Total Funding Raised
$6.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RAYDIAX is a medical technology company that develops a therapy-assistance computed tomography (CT) system for minimally invasive cancer interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RAYDIAX Comparables
Compare RAYDIAX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epica International, Inc. | 78% | |
| GE HealthCare Technologies Inc. | 74% | |
| Philips | 74% | |
RAYDIAX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2026 | ||||
| Seed | Oct 26, 2023 | ||||
| Grant | Oct 26, 2023 |
Key People
Founding team and executive leadership
RAYDIAX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Federal Ministry for Economic Affairs and Energy | Grant |
| GETEC Family Office | Grant |
| IBG Beteiligungsgesellschaft Sachsen-Anhalt | Seed |
| Bmp Ventures | Seed, Grant |
| High-Tech Gründerfonds | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
Open roles increased to 5, representing 25% of headcount.
RAYDIAX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RAYDIAX's valuation, stock price, and market status.